Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Homann

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Neuropharmacology|January 18, 2021
Novel compounds with dual S1P receptor agonist and histamine H<sub>3</sub> receptor antagonist activities act protective in a mouse model of multiple sclerosisFaik Imeri, Bisera Stepanovska Tanturovska, Aleksandra Zivkovic, et al.
Neuropharmacology|May 28, 2014
Novel oxazolo-oxazole derivatives of FTY720 reduce endothelial cell permeability, immune cell chemotaxis and symptoms of experimental autoimmune encephalomyelitis in miceFaik Imeri, Daniel Fallegger, Aleksandra Zivkovic, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Neuropharmacology|January 18, 2021
Novel compounds with dual S1P receptor agonist and histamine H<sub>3</sub> receptor antagonist activities act protective in a mouse model of multiple sclerosisFaik Imeri, Bisera Stepanovska Tanturovska, Aleksandra Zivkovic, et al.
Neuropharmacology|May 28, 2014
Novel oxazolo-oxazole derivatives of FTY720 reduce endothelial cell permeability, immune cell chemotaxis and symptoms of experimental autoimmune encephalomyelitis in miceFaik Imeri, Daniel Fallegger, Aleksandra Zivkovic, et al.
Pageof 3